LABA Withdrawal Increases Asthma-Related Impairment
Journal of the American Academy of Physician Assistants (HealthDay News) – For patients with asthma controlled with a combination of an inhaled corticosteroid (ICS) and a long-acting ?2-agonist (LABA), withdrawal of the LABA once asthma is controlled correlates with increased asthma-associated impairment. |
View full post on asthma – Google News